Clinical Trials Directory

Trials / Unknown

UnknownNCT04880148

The Effectiveness of a Thyme and Honey Spray for Oral Toxicities

The Effectiveness of a Thyme and Honey Spray for the Management of Oral Mucositis and Xerostomia in Head and Neck Cancer Patients Undergoing Radiotherapy

Status
Unknown
Phase
N/A
Study type
Interventional
Enrollment
200 (estimated)
Sponsor
Cyprus University of Technology · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

Aim: To evaluate the effectiveness of thymus honey on radiation induced-oral mucositis and xerostomia. Background: Oral mucositis and xerostomia are two of the most severe side effects that head and neck cancer patients confront during and after the completion of radiotherapy. Although several medications are used for their treatment, these fail to provide a fully effective and comprehensive management. Honey and thyme have been studied for the management of various treatment-related side effects. Design: Α double blinded randomised controlled trial will be used for this study. Methods: 200 head and neck cancer patients who receive radiotherapy will be included in this study. Patients will be randomised and divided into two equal groups of 100 participants; the intervention group (oral spray with thyme and honey + standard care) and the control group ( placebo spray + standard care). Assessments with xerostomia and oral mucositis scales additionally to 4 self-administered questionnaires will occur in both groups at baseline and then weekly and 6 months following completion of treatment. The duration of the study will be 3 years from the day of approval of this research protocol.

Conditions

Interventions

TypeNameDescription
DIETARY_SUPPLEMENTThyme and Honey-based oral spray4 X Sprays in the oral cavity before, immediately after and 6 hours following the radiotherapy session
DIETARY_SUPPLEMENTPlacebo oral spray4 X Sprays in the oral cavity before, immediately after and 6 hours following the radiotherapy session

Timeline

Start date
2021-11-03
Primary completion
2024-06-01
Completion
2024-09-01
First posted
2021-05-10
Last updated
2021-12-09

Locations

2 sites across 1 country: Cyprus

Source: ClinicalTrials.gov record NCT04880148. Inclusion in this directory is not an endorsement.